04.24.13
Vedic Lifesciences,Mumbai, India, has announced the successful issuance of a natural product number (NPN) license to one of its Canadian clients, SierraSil Health Inc. This was granted in part on the basis of a study plan drawn up by Vedic and the execution of a Proof of Concept Study designed to substantiate SierraSil’s claim ("used in the temporary relief of pain"). These key data, along with data generated in Canada, were submitted to the health regulatory authorities in Canada.
“This new NPN requirement by Canadian regulators for all Nutraceutical products that are being currently marketed in Canada, underscores the increasing need for the planning, speed and quality of services that Vedic provides to its clients, not only in Canada but worldwide”, said Kunal Bhatt, Vedic’s global manager, Business and Projects.
SierraSil’spresident Michael Bentley said “We are delighted to have achieved this critical approval from the Canadian authorities and appreciate Vedic Lifesciences’ role and helpful partnership in this accomplishment”
“We are gratified to contribute to this positive milestone for Sierrasil by being a reliable scientific and regulatory partner to our clients” said Jayesh Chaudhary, chief executive officer, Vedic Lifesciences.
“This new NPN requirement by Canadian regulators for all Nutraceutical products that are being currently marketed in Canada, underscores the increasing need for the planning, speed and quality of services that Vedic provides to its clients, not only in Canada but worldwide”, said Kunal Bhatt, Vedic’s global manager, Business and Projects.
SierraSil’spresident Michael Bentley said “We are delighted to have achieved this critical approval from the Canadian authorities and appreciate Vedic Lifesciences’ role and helpful partnership in this accomplishment”
“We are gratified to contribute to this positive milestone for Sierrasil by being a reliable scientific and regulatory partner to our clients” said Jayesh Chaudhary, chief executive officer, Vedic Lifesciences.
